PATH vs SCL
Uipath Inc (PATH) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the PATH and SCL stock pages for the full models.
Not investment advice.